IN8bio, Inc. INAB
NASDAQ · United States · Health Technology
$1.400.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.25 | -0.34 | +27.3% | $0 | — | -1.0%$0.99→$0.98 |
| Q1 2026 | 2026-05-07 | -0.26 | -0.59 | +55.9% | — | — | 0.0%$1.58→$1.58 |
| Q4 2025 | 2026-03-12 | -0.45 | -0.47 | +4.3% | — | — | -5.0%$1.99→$1.89 |
| Q3 2025 | 2025-11-06 | -0.85 | -1.20 | +29.2% | — | — | -4.9%$1.63→$1.55 |
| Q4 2024 | 2025-03-13 | -1.20 | -2.40 | +50.0% | — | — | — |
| Q4 2023 | 2024-03-14 | -6.30 | -4.60 | -37.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.